WARPTECHNEWS · LAB
HomeAIBusinessTechArchive
WARPTECH LAB NEWS

Warptech Lab News aggrega le notizie più rilevanti da oltre 700 fonti internazionali, con classificazione AI, TL;DR sintetici e timeline cluster su singole storie.

Navigazione

  • Home
  • Archivio
  • Editor's Brief
  • Cerca
  • Il tuo account
  • Newsletter tech/AI

Informazioni legali

  • Privacy Policy
  • Termini di servizio
  • Cookie Policy

© 2026 Sparktech S.R.L. — Tutti i diritti riservati. Sito gestito e manutenuto da Sparktech S.R.L.

Sede legale: Corso Libertà 55, 13100 Vercelli (VC), Italia · P.IVA / C.F. 02835910023 · Contatti: admin@warptechlab.com

Home
Storia in 3 fonti

Gilead teams up with WHO again to eliminate parasitic tropical disease - Pharmaceutical Technology

Gilead will donate vials of its antifungal medication AmBisome to help global efforts in eliminating visceral leishmaniasis.

Raccontata damorningstar.comfiercepharma.compharmaceutical-technology.com

Confronto fonti

3 prospettive sulla stessa storia
AI · summaries
pharmaceutical-technology.comStai leggendo4 g fa

Gilead teams up with WHO again to eliminate parasitic tropical disease - Pharmaceutical Technology

Gilead will donate vials of its antifungal medication AmBisome to help global efforts in eliminating visceral leishmaniasis.

originale
fiercepharma.com4 g fa

Gilead pledges 400K AmBisome doses to fight visceral leishmaniasis in expanded WHO collab

Gilead Sciences and the World Health Organization (WHO) are doubling down on a pact to eliminate deadly parasitic disea | Gilead’s five-year contract with the WHO is centered on providing AmBisome to countries that make…

Leggi questa versione →

Timeline cronologica

  1. giovedì 21 maggio 2026·morningstar.com

    Gilead Sciences and World Health Organization Expand Collaboration to Help Eliminate Visceral Leishmaniasis, a Fatal Parasitic Disease

    Gilead Sciences and World Health Organization Expand Collaboration to Help Eliminate Visceral Leishmaniasis, a Fatal Parasitic Disease

  2. giovedì 21 maggio 2026·fiercepharma.com

    Gilead pledges 400K AmBisome doses to fight visceral leishmaniasis in expanded WHO collab

    Gilead Sciences and the World Health Organization (WHO) are doubling down on a pact to eliminate deadly parasitic disea | Gilead’s five-year contract with the WHO is centered on…

originale
morningstar.com5 g fa

Gilead Sciences and World Health Organization Expand Collaboration to Help Eliminate Visceral Leishmaniasis,…

Gilead Sciences and World Health Organization Expand Collaboration to Help Eliminate Visceral Leishmaniasis, a Fatal Parasitic Disease

Leggi questa versione → originale
  • giovedì 21 maggio 2026·pharmaceutical-technology.com

    Gilead teams up with WHO again to eliminate parasitic tropical disease - Pharmaceutical Technology

    Gilead will donate vials of its antifungal medication AmBisome to help global efforts in eliminating visceral leishmaniasis.